{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:04:54Z","timestamp":1768712694069,"version":"3.49.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jvs.2022.09.022","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T23:49:53Z","timestamp":1664495393000},"page":"1264-1273.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["A systematic review and meta-analysis of sirolimus-eluting stents for treatment of below-the-knee arterial disease"],"prefix":"10.1016","volume":"77","author":[{"given":"Khi Yung","family":"Fong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josiah","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley E.K.","family":"Loh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Jie","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7171-4516","authenticated-orcid":false,"given":"Andrew M.T.L.","family":"Choong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl S","key":"10.1016\/j.jvs.2022.09.022_bib1","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.09.022_bib2","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/CIRCRESAHA.121.318535","article-title":"Epidemiology of peripheral artery disease and polyvascular disease","volume":"128","author":"Aday","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.jvs.2022.09.022_bib3","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1067\/mhj.2002.122871","article-title":"Prevalence and clinical correlates of peripheral arterial disease in the Framingham offspring study","volume":"143","author":"Murabito","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvs.2022.09.022_bib4","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.jvs.2015.07.065","article-title":"The natural history of untreated severe or critical limb ischemia","volume":"62","author":"Abu Dabrh","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.09.022_bib5","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejvs.2017.07.005","article-title":"Amputation rates, mortality, and pre-operative comorbidities in patients revascularised for intermittent claudication or critical limb ischaemia: a population based study","volume":"54","author":"Baubeta Fridh","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2022.09.022_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.avsg.2016.09.008","article-title":"Tibioperoneal occlusive disease: a review of below the knee endovascular therapy in patients with critical limb ischemia","volume":"38","author":"Muir","year":"2017","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2022.09.022_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jvs.2019.05.002","article-title":"Critical review and evidence implications of paclitaxel drug-eluting balloons and stents in peripheral artery disease","volume":"70","author":"Mills","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.09.022_bib8","first-page":"124","article-title":"SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions","volume":"92","author":"Feldman","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2022.09.022_bib9","doi-asserted-by":"crossref","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvs.2022.09.022_bib10","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jamacardio.2019.0325","article-title":"Association of survival with femoropopliteal artery revascularization with drug-coated devices","volume":"4","author":"Secemsky","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jvs.2022.09.022_bib11","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1056\/NEJMoa2005206","article-title":"Mortality with paclitaxel-coated devices in peripheral artery disease","volume":"383","author":"Nordanstig","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2022.09.022_bib12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejvs.2021.05.027","article-title":"Editor's choice \u2013 risk of major amputation following application of paclitaxel coated balloons in the lower limb arteries: a systematic review and meta-analysis of randomised controlled trials","volume":"63","author":"Katsanos","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2022.09.022_bib13","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.09.022_bib14","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1161\/CIRCULATIONAHA.119.041099","article-title":"Paclitaxel-coated balloons and eluting stents: is there a mortality risk in patients with peripheral artery disease?","volume":"140","author":"Beckman","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2022.09.022_bib15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ejvs.2021.06.006","article-title":"Drug coated balloons for dysfunctional haemodialysis venous access: a patient level meta-analysis of randomised controlled trials","volume":"62","author":"Fong","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2022.09.022_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1583\/09-2691.1","article-title":"Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients","volume":"16","author":"Biondi-Zoccai","year":"2009","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2022.09.022_bib17","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jvs.2022.09.022_bib18","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jvs.2022.09.022_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/XEB.0000000000000152","article-title":"The development of software to support multiple systematic review types: the Joanna Briggs Institute system for the unified management, assessment and review of information (JBI SUMARI)","volume":"17","author":"Munn","year":"2019","journal-title":"Int J Evid Based Healthc"},{"key":"10.1016\/j.jvs.2022.09.022_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12874-021-01308-8","article-title":"IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jvs.2022.09.022_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2288-12-9","article-title":"Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves","volume":"12","author":"Guyot","year":"2012","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jvs.2022.09.022_bib22","first-page":"171","article-title":"Percutaneous transluminal angioplasty for treatment of ''below-the-knee'' critical limb ischemia: early outcomes following the use of sirolimus-eluting stents","volume":"47","author":"Bosiers","year":"2006","journal-title":"J\u00a0Cardiovasc Surg"},{"key":"10.1016\/j.jvs.2022.09.022_bib23","first-page":"793","article-title":"Sirolimus for below the knee lesions: mid-term results of SiroBTK study","volume":"68","author":"Commeau","year":"2006","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2022.09.022_bib24","first-page":"169","article-title":"Comparison of sirolimus-eluting vs. bare-metal stents for the treatment of infrapopliteal obstructions","volume":"2","author":"Scheinert","year":"2006","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jvs.2022.09.022_bib25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/152660280701400217","article-title":"Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit","volume":"14","author":"Siablis","year":"2007","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2022.09.022_bib26","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jvir.2009.05.031","article-title":"Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome","volume":"20","author":"Siablis","year":"2009","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvs.2022.09.022_bib27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1583\/05-1620MR.1","article-title":"Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study","volume":"12","author":"Siablis","year":"2005","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2022.09.022_bib28","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1007\/s00330-008-1225-1","article-title":"The evaluation of primary stenting of sirolimus-eluting versus bare-metal stents in the treatment of atherosclerotic lesions of crural arteries","volume":"19","author":"Falkowski","year":"2009","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jvs.2022.09.022_bib29","first-page":"183","article-title":"Percutaneous interventions below the knee in patients with critical limb ischemia using drug eluting stents","volume":"51","author":"Balzer","year":"2010","journal-title":"J\u00a0Cardiovasc Surg"},{"key":"10.1016\/j.jvs.2022.09.022_bib30","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1583\/10-3073.1","article-title":"Primary use of sirolimus-eluting stents in the infrapopliteal arteries","volume":"17","author":"Rastan","year":"2010","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2022.09.022_bib31","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2012.04.035","article-title":"Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial","volume":"60","author":"Rastan","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2022.09.022_bib32","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1093\/eurheartj\/ehr144","article-title":"Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial","volume":"32","author":"Rastan","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2022.09.022_bib33","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.jacc.2012.08.989","article-title":"A\u00a0prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial","volume":"60","author":"Scheinert","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2022.09.022_bib34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1583\/11-3665.1","article-title":"Sirolimus-eluting stents for the treatment of infrapopliteal arteries in chronic limb ischemia: long-term clinical and angiographic follow-up","volume":"19","author":"Werner","year":"2012","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2022.09.022_bib35","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/CIRCULATIONAHA.106.613588","article-title":"Primary stenting of totally occluded native coronary arteries II (PRISON II)","volume":"114","author":"Suttorp","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2022.09.022_bib36","first-page":"181","article-title":"Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions","volume":"67","author":"Kim","year":"2006","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2022.09.022_bib37","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa051175","article-title":"Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization","volume":"353","author":"Windecker","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2022.09.022_bib38","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/CIRCULATIONAHA.115.018034","article-title":"Drug-eluting stents are the default strategy for superficial femoral artery intervention now","volume":"133","author":"Burket","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2022.09.022_bib39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/01.RVI.0000151260.74519.CA","article-title":"Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial","volume":"16","author":"Duda","year":"2005","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvs.2022.09.022_bib40","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1583\/05-1704.1","article-title":"Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial","volume":"13","author":"Duda","year":"2006","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2022.09.022_bib41","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1526602819881156","article-title":"What now for the endovascular community after the paclitaxel mortality meta-analysis: can sirolimus replace paclitaxel in the peripheral vasculature?","volume":"27","author":"Tang","year":"2020","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2022.09.022_bib42","first-page":"18","article-title":"The market reacts quickly: changes in paclitaxel vascular device purchasing within the Ascension Healthcare System","volume":"32","author":"Monteleone","year":"2020","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jvs.2022.09.022_bib48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.23736\/S0392-9590.19.04049-5","article-title":"The use of drug-eluting stents in infrapopliteal arteries: an updated systematic review and meta-analysis of randomized trials","volume":"38","author":"Varcoe","year":"2019","journal-title":"Int Angiol"},{"key":"10.1016\/j.jvs.2022.09.022_bib49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejvs.2019.10.002","article-title":"Editor's choice \u2013 drug coated balloon angioplasty vs. standard percutaneous transluminal angioplasty in below the knee peripheral arterial disease: a systematic review and meta-analysis","volume":"59","author":"Ipema","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2022.09.022_bib43","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/15266028211023505","article-title":"Mortality rates after paclitaxel-coated device use in patients with occlusive femoropopliteal disease: an updated systematic review and meta-analysis of randomized controlled trials","volume":"28","author":"Dinh","year":"2021","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2022.09.022_bib44","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1161\/CIRCULATIONAHA.119.044697","article-title":"Mortality and paclitaxel-coated devices","volume":"141","author":"Rocha-Singh","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2022.09.022_bib45","doi-asserted-by":"crossref","first-page":"e006285","DOI":"10.1161\/CIRCINTERVENTIONS.117.006285","article-title":"Leave no stent behind","volume":"11","author":"Sethi","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2022.09.022_bib46","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/CIRCULATIONAHA.115.018035","article-title":"Endovascular therapy for femoropopliteal disease: drug-eluting stents are not the default therapy","volume":"133","author":"Garcia","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2022.09.022_bib47","first-page":"1284","article-title":"Drug-eluting stents for revascularization of infrapopliteal arteries","volume":"6","author":"Fusaro","year":"2013","journal-title":"JACC: Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2022.09.022_bib50","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1177\/2047487317736824","article-title":"Cardiovascular outcomes for patients with symptomatic peripheral artery disease: a cohort study in the Health Improvement Network (THIN) in the UK","volume":"24","author":"Cea Soriano","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jvs.2022.09.022_bib51","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1526602820969681","article-title":"Drug-coated balloon angioplasty compared with uncoated balloons in the treatment of infrapopliteal artery lesions (AcoArt II\u2013BTK)","volume":"28","author":"Jia","year":"2020","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2022.09.022_bib52","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1177\/1526602816671740","volume":"23","author":"Katsanos","year":"2016","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2022.09.022_bib53","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.avsg.2019.02.021","article-title":"A\u00a0network meta-analysis of randomized controlled trials comparing treatment modalities for infrapopliteal lesions in critical limb ischemia","volume":"60","author":"Zhou","year":"2019","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2022.09.022_bib54","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/CIRCULATIONAHA.113.001811","article-title":"Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK)","volume":"128","author":"Liistro","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2022.09.022_bib55","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa051303","article-title":"Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery","volume":"354","author":"Schillinger","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2022.09.022_bib56","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2018.11.039","article-title":"Drug-eluting stent versus drug-coated balloon revascularization in patients with femoropopliteal arterial disease","volume":"73","author":"Bausback","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2022.09.022_bib57","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jvir.2018.02.006","article-title":"Biologic drug effect and particulate embolization of drug-eluting stents versus drug-coated balloons in healthy swine femoropopliteal arteries","volume":"29","author":"Torii","year":"2018","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvs.2022.09.022_bib58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1586\/erd.11.67","article-title":"Below-the-knee drug-eluting stents and drug-coated balloons","volume":"9","author":"Karnabatidis","year":"2012","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.jvs.2022.09.022_bib59","doi-asserted-by":"crossref","first-page":"e0241321","DOI":"10.1371\/journal.pone.0241321","article-title":"Early (6 months) results of a pilot prospective study to investigate the efficacy and safety of sirolimus coated balloon angioplasty for dysfunctional arterio-venous fistulas: MAgicTouch intervention leap for dialysis access (MATILDA) trial","volume":"15","author":"Tang","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jvs.2022.09.022_bib60","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/1526602820941811","article-title":"Six-month outcomes from the first-in-human, single-arm SELUTION sustained-limus-release drug-eluting balloon trial in femoropopliteal lesions","volume":"27","author":"Zeller","year":"2020","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2022.09.022_bib61","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/1358863X20977907","article-title":"Mid-term outcomes of an everolimus-eluting bioresorbable vascular scaffold in patients with below-the-knee arterial disease: a pooled analysis of individual patient data","volume":"26","author":"Huizing","year":"2021","journal-title":"Vasc Med"},{"key":"10.1016\/j.jvs.2022.09.022_bib62","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/jama.295.8.895","article-title":"Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions the REALITY trial: a randomized controlled trial","volume":"295","author":"Morice","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2022.09.022_bib63","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/eurheartj\/ehl545","article-title":"A\u00a0call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries","volume":"28","author":"Diehm","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2022.09.022_bib64","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jvs.2016.03.420","article-title":"Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease","volume":"64","author":"Stoner","year":"2016","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.09.022_bib65","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00270-022-03104-3","article-title":"Drug-eluting balloon for below the knee angioplasty: five-year outcome of the DEBATE-BTK randomized clinical trial","volume":"45","author":"Liistro","year":"2022","journal-title":"Cardiovasc Interv Radiol"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521422023205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521422023205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:39:54Z","timestamp":1760042394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521422023205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0741521422023205"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2022.09.022","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review and meta-analysis of sirolimus-eluting stents for treatment of below-the-knee arterial disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2022.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the Society for Vascular Surgery. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}